Antiparasitic agents

Abstract

The present invention relates to compounds of the formula (I) or a tautomer or prodrug thereof, or a pharmaceutically acceptable salt of said compound, tautomer or prodrug, wherein: R 1 , R 2 , R 3 , R 4 and R 5 are each independently selected from H, halo, CN, CF 3 and CONH 2 ; compositions containing such compounds and the uses of such compounds as antiparasitic agents.

1 . A compound of the formula 
     
       
         
         
             
             
         
       
       or a tautomer or prodrug thereof, or a pharmaceutically acceptable salt of said compound, tautomer or prodrug, wherein: 
       R 1 , R 2 , R 3 , R 4  and R 5  are each independently selected from H, halo, CN, CF 3  and CONH 2 . 
     
   
   
       2 . A compound according to  claim 1  wherein R 1 , R 2 , R 3 , R 4  and R 5  are each independently selected from H, F, Cl, Br, CN and CF 3 . 
   
   
       3 . A compound according to  claim 2  wherein at least one of R 1 , R 2 , R 3 , R 4  and R 5  is CN and at least two of R 1 , R 2 , R 3 , R 4  and R 5  are H. 
   
   
       4 . A compound according to  claim 2  wherein R 1  and R 4  are H, one of R 2  and R 3  is H and the other is CN, and R 5  is selected from F, Cl, Br and CF 3 . 
   
   
       5 . A compound according to  claim 4  wherein R 3  is CN and R 5  is CF 3 . 
   
   
       6 . A compound according to  claim 1  selected from:
 N-{1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide,   N-{(1R)-1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide,   N-{(1S)-1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide,   N-[2-(2-chloro-5-cyanophenoxy)-1-cyano-1-methylethyl]-4-pentafluorothiobenzamide,   N-[2-(2-chloro-5-cyanophenoxy)-(1R)-1-cyano-1-methylethyl]-4-pentafluorothiobenzamide,   N-[2-(2-chloro-5-cyanophenoxy)-(1S)-1-cyano-1-methylethyl]-4-pentafluorothiobenzamide,   N-{1-cyano-2-[4-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide,   N-{(1R)1-cyano-2-[4-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide,   N-{(1S)1-cyano-2-[4-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide,   N-{2-[2-chloro-5-cyano-3-(trifluoromethyl)phenoxy]-1-cyano-1-methylethyl}-4-pentafluorothiobenzamide,   N-{2-[2-chloro-5-cyano-3-(trifluoromethyl)phenoxy]-(1R)-1-cyano-1-methylethyl}-4-pentafluorothiobenzamide,   N-{2-[2-chloro-5-cyano-3-(trifluoromethyl)phenoxy]-(1S)-1-cyano-1-methylethyl}-4-pentafluorothiobenzamide,   N-[2-(2-chloro-4,5-dicyanophenoxy)-1-cyano-1-methylethyl]-4-pentafluorothiobenzamide,   N-[2-(2-chloro-4,5-dicyanophenoxy)-(1R)-1-cyano-1-methylethyl]-4-pentafluorothiobenzamide,   N-[2-(2-chloro-4,5-dicyanophenoxy)-(1S)-1-cyano-1-methylethyl]-4-pentafluorothiobenzamide,   N-(1-cyano-2-[4-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl)-4-pentafluorothiobenzamide,   N-{(1R)-1-cyano-2-[4-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide, and   N-{(1S)-1-cyano-2-[4-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide,   or a pharmaceutically acceptable salt thereof.   
   
   
       7 . A pharmaceutical composition comprising a compound of formula (I) of  claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier 
   
   
       8 . The pharmaceutical composition according to  claim 7  further comprising a second therapeutic agent. 
   
   
       9 . The pharmaceutical composition according to  claim 8  wherein the second therapeutic agent is selected from ivermectin, avermectin, abamectin, emamectin, eprinomectin, doramectin, selamectin, moxidectin, nemadectin, milbemycin oxime, albendazole, cambendazole, fenbendazole, flubendazole, mebendazole, oxfendazole, oxibendazole, parbendazole, tetramisole, levamisole, pyrantel pamoate, oxantel, morantel, closantel, triclabendazole, clorsulon, rafoxanide, niclosamide, praziquantel, epsiprantel, 2-desoxoparaherquamide, fipronil, pyriprole, pyrafluprole, lufenuron, spiromesifen, tebufenozide, tebufenozide, spinosad, spinetoram, imidacloprid, dinotefuran, metaflumizone, flubendiamide, chlorantraniliprole, indoxacarb, pyridalyl, pyrimidifen and pyrifluquinazon. 
   
   
       10 . A method of treatment of a parasitic infestation in a host animal, comprising treating said host animal with an effective amount of a compound of formula (I), or with a pharmaceutically acceptable salt or composition thereof, as defined in  claim 1 . 
   
   
       11 . The method according to  claim 10  wherein the host animal is a non-human animal. 
   
   
       12 . The method according to  claim 10  wherein the parasite is a nematode.